BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Quercetin
,
rs3825942
,
TGFB1
,
calcium channel activity
,
Inflammatory disorder
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
JAK inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
Ovarian cancer model treated with JAK inhibitor AZD1480
White-to-brown metabolic conversion of adipocytes by JAK inhibition
Skin biopsies of atopic dermatitis patients treated with oral dual JAK/SYK inhibitor ASN002
Epithelial cells from small airway treated with interferons, Baricitinib or Ruxolitinib
Lung cancer NCI-H1573, NCI-H1992, NCI-H596 cells treated with Crizotinib, IFN gamma and HGF
Explore Curated Studies Results
Literature
Most Relevant Literature
JAK inhibitors ∼ overview∼.
Emerging role of topical Janus kinase inhibitors in dermatological disorders: a review.
Janus Kinase Inhibitors: A Promising Therapeutic Option for Allergic Contact Dermatitis.
Abrocitinib: First Globally Approved Selective Janus Kinase-1 Inhibitor for the Treatment of Atopic …
Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor Tha…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
JAK Inhibitor Treatment in AGS
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
Safety and Retention Rate of the JAK Inhibitors in Rheumatoid Arthritis: a Real-life Experience
Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors (VACCIMIL-ZOSTER)
Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ